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Influence of maternal breast milk ingestion
on acquisition of the intestinal microbiome
in preterm infants
Katherine E. Gregory1*†, Buck S. Samuel 2†, Pearl Houghteling3, Guru Shan4, Frederick M. Ausubel5,
Ruslan I. Sadreyev6 and W. Allan Walker7

Abstract
Background: The initial acquisition and early development of the intestinal microbiome during infancy are
important to human health across the lifespan. Mode of birth, antibiotic administration, environment of care,
and nutrition have all been shown to play a role in the assembly of the intestinal microbiome during early
life. For preterm infants, who are disproportionately at risk of inflammatory intestinal disease (i.e., necrotizing
enterocolitis), a unique set of clinical factors influence the establishment of the microbiome. The purpose of
this study was to establish the influence of nutritional exposures on the intestinal microbiome in a cohort of
preterm infants early in life.
Results: Principal component analysis of 199 samples from 30 preterm infants (<32 weeks) over the first
60 days following birth showed that the intestinal microbiome was influenced by postnatal time (p < 0.001,
R2 = 0.13), birth weight (p < 0.001, R2 = 0.08), and nutrition (p < 0.001, R2 = 0.21). Infants who were fed breast
milk had a greater initial bacterial diversity and a more gradual acquisition of diversity compared to infants
who were fed infant formula. The microbiome of infants fed breast milk were more similar regardless of birth
weight (p = 0.049), in contrast to the microbiome of infants fed infant formula, which clustered differently
based on birth weight (p < 0.001). By adjusting for differences in gut maturity, an ordered succession of
microbial phylotypes was observed in breast milk-fed infants, which appeared to be disrupted in those fed
infant formula. Supplementation with pasteurized donor human milk was partially successful in promoting a
microbiome more similar to breast milk-fed infants and moderating rapid increases in bacterial diversity.
Conclusions: The preterm infant intestinal microbiome is influenced by postnatal time, birth weight,
gestational age, and nutrition. Feeding with breast milk appears to mask the influence of birth weight,
suggesting a protective effect against gut immaturity in the preterm infant. These findings suggest not only a
microbial mechanism underpinning the body of evidence showing that breast milk promotes intestinal health
in the preterm infant but also a dynamic interplay of host and dietary factors that facilitate the colonization
of and enrichment for specific microbes during establishment of the preterm infant microbiota.
Keywords: Preterm infant, Intestinal colonization, Microbiome, Breast milk, Nutrition, Newborn intensive care
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Background
The initial acquisition and early development of the intestinal microbiome during infancy are important to human health across the lifespan [1–3]. Several factors
influence the assembly of the intestinal microbiome during infancy. Mode of birth [4], antibiotic administration
[5], environment of care [6], and nutritional exposures,
and most notably breastfeeding [7] have all been shown
to play an important role in acquisition of the intestinal
microbiome. Exposure to breast milk during infancy appears to be particularly important in shaping the microbiome [8]. Among preterm infants, gestational age at
birth and postnatal age at observation have also been
shown to be relevant to the characteristics of their
microbiome [9]. We know from clinical studies that exclusively breastfed full-term infants harbor specific
health-promoting bacteria (“pioneer” bacteria) that are
associated with improved immune status [8, 10]. We
also know that the microbiota of breast- vs. formula-fed
infants have a more profound effect on neonatal enterocyte genes that influence host protection and development [10]. What is not known is the impact of ingested
expressed breast milk from mothers delivering prematurely on the composition of the preterm infant’s intestinal microbiome.
Children who are born preterm suffer a myriad of
complications as a result of immature organs that are
ill suited for the extrauterine environment at the time
of their birth. Of the preterm infant patient population, those born prior to 32 weeks are especially vulnerable. These children require the majority of health
care resources available because they are at the highest risk of neonatal morbidities, many of which have
a lasting influence on health throughout childhood
and across the lifespan [11, 12].
Preterm infants born prior to 32 weeks of gestation
are disproportionately at risk for excessive intestinal inflammatory conditions, particularly necrotizing enterocolitis (NEC). NEC affects approximately 10% of
preterm infants born less than 1500 g and is a major
contributor to neonatal morbidity and mortality [13].
Preterm infants are also commonly at risk for intestinal
dysbiosis that is associated with birth by cesarean section, maternal infection (e.g., chorioamnionitis), routine
administration of antibiotics during the perinatal period,
and a decreased exposure to maternal breast milk. In
sum, intestinal dysbiosis in a preterm infant is problematic for both short- and long-term health and is thought
to be a major risk factor for NEC [14].
Human breast milk is strongly recommended by the
Committee on Nutrition of the European Society of
Paediatric Gastroenterology, Hepatology and Nutrition
as the best source of nutrition for newborn infants,
including preterm infants [15]. Breast milk contains
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important developmental and immune-promoting factors (oligosaccharides, immunoglobulins, etc.) that are
thought to protect the newborn both passively and
actively against excessive intestinal inflammation [16].
Specifically, the ingestion of maternal breast milk
(MBM) from mothers delivering prematurely, particularly when given as soon as possible after birth, is
considered a preventative measure for the development of NEC [17, 18]. In the absence of expressed
MBM, pasteurized donor human milk (PDHM) or a
specialized preterm infant formula (IF) is used as the
enteric source of nutrition in this population. However, neither of these latter nutritional approaches is
as effective as MBM in establishing optimal immune
health or in the prevention of NEC [19].
Recognizing that breast milk influences initial bacterial
colonization and that MBM given to preterm infants can
prevent NEC, we analyzed the influence of different
forms of infant nutrition on the initial colonization
process in 30 preterm infants. Few longitudinal studies
evaluating the influence of nutrition on the preterm infant’s intestinal microbiome have been conducted, and
to our knowledge, no study has evaluated the influence
of PDHM on the early acquisition of the intestinal
microbiome and how this differs from MBM and infant
formula. Thus, the purpose of this study was to determine the composition of the intestinal microbiome of 30
preterm infants born <32 weeks of gestation for a period
of approximately 6 weeks after birth who had been exposed to different nutritional regimens.

Results
Diet, maturity, and postnatal age are the greatest drivers
of preterm infant microbiome composition

This study included three groups of 10 preterm infants
born prior to 32 weeks of gestation (n = 30). The infants
were grouped based on a predominant diet of MBM,
PDHM, or IF. Stool samples were collected daily while
the infant was hospitalized, and weekly samples were analyzed for microbiome compositional differences using
16S rDNA-based sequencing.
As shown in Fig. 1, 40% of the variance in microbiome
composition is explained by the first three principal
components (Bray-Curtis PCA, which best explained the
variance in the data among the metrics tested; see
“Methods” section). In Fig. 1a, the clustering in microbiome samples based on diet are shown, where the majority of the MBM samples cluster separately from the IF
samples. Figure 1b shows that the birth weight of the infant at the time of birth also contributes to the clustering of the microbiome, with infants born less than
1000 g (ELBW) grouped separately from infants born
greater than 1000 g (VLBW). MBM samples cluster together regardless of birth weight, whereas IF samples

Gregory et al. Microbiome (2016) 4:68

Fig. 1 (See legend on next page.)
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(See figure on previous page.)
Fig. 1 Infant microbiota composition in preterm gut driven by diet and birth weight. Principal component analysis (PCA) of 199 samples from
the 30 infants over the first 60 days based on Bray-Curtis distances between samples [2000 reads/sample]. Scatterplots are colored based on the
following: a nutritional exposures on a sample-by-sample basis [MBM maternal breast milk, DM pasteurized human donor milk, IF infant formula,
NPO nil per os, nothing by mouth]; b birth weight class [VLBW very low birth weight infants 1000–1500 g, ELBW extremely low birth weight infants
<1000 g]; and c week of life [shades of yellow—“early” samples <3 weeks; shades of blue—“late” samples after 3 weeks]. Early samples cluster
together regardless of nutritional exposures. Closer proximity of samples (points) equals more similar microbiota composition. Separation
of samples within each category is significant [FDR-adjusted PERMANOVA p < 0.001], and R2 values are noted

formed two clusters by birth weight and gestational age.
Figure 1c illustrates that postnatal week of life also appears to have a dominant role in determining microbiome composition that is largely independent of diet, as
most samples after the first 3 weeks of life (“late”) clustered together along PC1 (18% of variance) separate
from all of the samples within this period (“early”). This
clustering is further supported based on unweighted
UniFrac-based analyses of microbiome composition
(Fig. 2).
Distinct trajectories of bacterial diversity by diet

Following the initial PCA analyses that highlighted the
importance of the infant’s age following birth (i.e., week
of life) with regard to diet in our analyses, we sought to

identify the differences in diversity (as assessed using
Shannon indices; listed in Additional file 1: Table S2)
over time in the microbiome between the different infant feeding groups. To account for the nonindependence of the samples given that multiple samples
were collected from the same infant over time, we used
a linear mixed-effects modeling approach (similar to
[20]) in order to control for the non-independence of
the samples and account for different trajectories based
on gestational age of the infants. All three nutrition
groups exhibit a significant increase in bacterial diversity over postnatal time (Fig. 3a and Additional file 1:
Table S3), though the groups are especially distinct
with regard to the trajectories with which they increase in diversity from birth over the 60-day period.

Fig. 2 Unweighted UniFrac-based analyses of microbiomes. Clustering of samples using phylogeny-based, unweighted (“presence-absence”)
UniFrac metric of microbiome composition [6965 reads/sample; ellipses for each point represent 95% confidence intervals based on jackknifed (1000×)
values]. Samples are colored based on a study group, b birth weight class, and c nutritional exposures. Only samples with >3 weeks postnatal age are
plotted [123 samples]. Separation of samples within each category is significant [FDR-adjusted PERMANOVA p < 0.001], and R2 values are noted
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Fig. 3 Comparison of microbial diversity trajectories by diet and maturity. Linear mixed-effects (LME) model regressions of microbial diversity
(Shannon index) plotted by a postnatal day and b adjusted gestational age [gestational age + postnatal day at time of sample collection].
Adjusted gestational age reflects the overall maturity of the infant at the time of sample collection. Samples plotted included those >7 days post
antibiotic exposure for both panels [118 samples]. Lines represent linear mixed-effects regressions (and 95% confidence intervals) of Shannon diversity
over time for each infant (birth gestational age also included as a factor in panel a). The significance level for relating bacterial diversity over time
within each diet group is noted, as are the correlations and variance (panel c; based on “random effects”) of the model fit

Bacterial diversity levels started more simply but
rapidly increased to higher ultimate diversity levels in
IF- and PDHM-fed samples compared to matched
MBM-fed infant samples that exhibited a more measured initial increase in diversity. Further, variance
and confidence intervals for the models of PDHMand IF-fed infants were notably high. Adjusting for
gestational age better accounted for the differences in
trajectories for all nutritional groups (Fig. 3b), that is,
there was a 13–579% reduction in overall variance
with almost no variance (0.0001) observed in random
effects models for MBM infants diversity trajectories,
as well as both strong correlations to the model fit
lines and much lower confidence intervals for both
PDHM- and IF-fed infants (Fig. 3c). This suggests
again that gestational age (or gut maturity) had as
much influence on the diversity of the microbiome as
any dietary regimen.
We also observed that infant formula-fed infants appear to be most susceptible to differences in gut maturity compared to MBM-fed infants. Stratification of the
groups based on birth weight or birth gestational age
and week of life [early <3 weeks vs. late >3 weeks] suggested that microbial diversity for both IF-fed babies and
to a lesser extent PDHM-fed babies were significantly

influenced by gut maturity in late samples, whereas
MBM-fed babies exhibited no significant differences in
bacterial diversity (Additional file 2: Figure S2).
Succession of bacteria delayed by influence of gestational
age in IF-fed infants

As seen in Fig. 4a (and Additional file 1: Table S3), the
preterm infant gut is overwhelmingly comprised of species from Bacillales and Lactobacillales until approximately 28–30 weeks of adjusted gestational age,
particularly in IF-fed infants, and most strikingly in IF
(and to a lesser extent PDHM)-fed ELBW infants that
retain high levels of Lactobacillales during the entire
period monitored. The infants fed MBM have a greater
initial diversity in their microbiome that is most strongly
influenced by the presence of a variety of phylotypes that
include lower levels of Bacillales and Lactobacillales, in
favor of Clostridia, and Enterobacteriales as early as
26 weeks of adjusted gestational age.
We compared the overall compositional differences of
the infant microbiome based on nutrition in samples obtained after 3 weeks, with no antibiotic exposure within
7 days, and fit these to a linear mixed-effects models by
adjusted gestational age (see the “Methods” section;
Fig. 4b). Under both MBM and PDHM conditions, we
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Fig. 4 Distinct succession of bacteria as a function of diet and maturity. a Mean class level microbiota relative abundance in VLBW and ELBW
infants by nutritional group and adjusted gestational age. b Linear mixed-effects (LME) modeled relative abundance and statistical analyses of the
four most common types of bacteria identified: Bacillales, Lactobacillales, Clostridiales, and Enterobacteriales reported by nutritional group
and adjusted gestational age [>3 weeks postnatal age, >7 days post antibiotics samples only plotted; 86 samples]. Individual infant trajectories (lines)
for each infant are plotted along with box and whiskers for LME-modeled relative abundance values. FDR-adjusted p values from the LME models
are noted
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observed a relatively ordered succession in bacterial taxa
with initial colonization dominated by Bacillales/Lactobacillales giving way to Enterobacteriales then Clostridiales
and Bifidobacteriales. With IF feeding, a different trend
emerged where higher initial and persistent levels of Bacilliales/Lactobacillales seemed to delay colonization by
other taxa. The most striking trend was related to the
Enterobacteriales and was not observed at appreciable
levels until an adjusted gestational age of 34 weeks for IFfed babies while MBM-fed babies had high levels of Enterobacteriales from the 29th week. This also in turn appeared to correlate with higher colonization levels of
Lactobacillales and to some extent less colonization of
Clostridiales. Support of the hypothesis that the delay in
appearance of Enterobacteriales is a consequence of specific Bacillales/Lactobacillales inhibiting colonization of
Enterobacteriales comes from negative correlations between particular genera within these groups (e.g., inverse
Spearman correlations between Bacillus and Citrobacter;
Additional file 3: Figure S3). Other differences between
the groups included a more rapid increase in Clostridiales
in the MBM and PDHM groups compared to the IF group
and lower overall relative abundance of Lactobacillales in
the MBM group compared to the IF and PDHM group.
Together, these observations suggest a dynamic interplay
between host and dietary selection of specific members of
the microbiome that is disrupted by feeding of infant
formula.
We next sought to investigate the influence, if any, of
nutrition on establishment of microbiome composition
by maturity of the infant at birth, as measured by gestational age at birth (Fig. 5a; samples > 3 weeks post birth).
Again, the infants who were fed MBM cluster together
regardless of birth weight (p = 0.049, R2 = 0.102) whereas
the infants fed infant formula cluster distinctly from one
another based on birth weight (p < 0.001, R2 = 0.568).
This finding may indicate that breast milk protects
against bowel immaturity associated with low birth
weight, whereas in contrast, the community composition
of infants fed IF can still be distinguished based on birth
weight. In Fig. 5b (and Additional file 1: Table S4), we
show the relative abundance of the 10 most common
classes of bacteria measured in our samples. Statistically
significant differences (based on the LME tests above) in
the MBM group were identified Clostridiales (p = 0.002).
In the IF group, statistically significant differences were
identified in Clostridiales (p = 0.028), Enterobacteriales,
and Lactobacillales (p < 0.01). In the IF-fed group, the
most significant differences were identified in the Clostridiales, with VLBW infants having nearly ten times the
amount as ELBW infants.
Furthermore, we employed linear effect size feature selection (LEfSe; [21]) to identify specific taxa that were
significantly associated with either MBM or IF diets
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(Fig. 6). Enterobacteriales (specifically the Citrobacter)
and select Clostridiales (specifically Clostridium, Ruminococcus, and Negativicoccus) were identified as the best
discriminators of MBM-fed infants. For IF-fed infants,
Lactobacillales (specifically Streptococcus), Bacillus, and
a distinct Clostridiales (Anaerococcus) were associated
with this group. The negative correlations in taxa relative abundance observed above (Additional file 3: Figure
S3) between Citrobacter and Bacillus likely reflect dietdriven differences in these infant microbiomes. Together,
these analyses indicate that there are at least a handful
of signature taxa that characterize each nutritional regimen once a threshold of gut maturity is achieved.

Discussion
We know that initial colonization of the newborn gut
influences the development of intestinal host defense
[22, 23] and appropriate development may have a
profound effect on immune health during infancy and
throughout life [24]. This is in part because intestinal
immune health is immature at birth and develops in
conjunction with the initial colonization process. A
disruption in colonization and development of intestinal
host defense may account for the increase in allergy and
immune-mediated morbidity (i.e., autoimmune disease) in
developed countries over the last half century [25].
The host defense competency of the premature intestine is particularly immature and does not respond
to initial colonization in a manner similar to full
term, vaginally born, and breastfed infants [26]. For
example, we have shown that premature enterocytes
respond to an inflammatory stimulus with excessive
inflammation and can react to commensal bacteria
with higher levels of inflammation compared to mature human enterocytes [27, 28]. This suggests that
dysbiosis during the newborn period of preterm infants may contribute to excessive intestinal inflammation leading to NEC.
We also know that breast milk as an exclusive source
of nutrition in full-term infants stimulates healthpromoting bacteria, known as “pioneer” bacteria that
directly influence the development of host defense [29].
We also know that expressed breast milk from mothers
delivering prematurely protects the infant from NEC
[17, 18]. Although breast milk contains many passive
protective factors (IgA, oligosaccharides, lactoferrin, etc.)
that may contribute to the protection against inflammation and NEC, it may also provide an active role in the
stimulation of health-promoting bacteria that provide
protection against NEC. Several studies have suggested
that probiotics given to preterm infants may also protect
against NEC [30], and a recent report suggests that a
combination of probiotics and breast milk may be most
protective [31]. Since no studies have been conducted to
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Fig. 5 Impact of diet on microbiome composition by maturity. a PCA scatterplots of microbiota composition in late (>3 week) samples only by
nutritional group. b Relative abundance of the 10 most common classes of bacteria measured. # indicate significance based on LME modeling as
a function of adjusted gestational age (FDR-adjusted p > 0.05; Additional file 1: Table S4)

determine the influence of breast milk on intestinal
colonization in preterm infants, we studied the composition of intestinal microbiota in preterm infants using
three standard feeding regimes: (1) exclusive ingestion of
expressed MBM; (2) ingestion of PDHM followed by IF;
and (3) exclusive ingestion of preterm IF. We hypothesized that ingestion of expressed MBM by preterm infants may also promote a healthy gut by the stimulation

of a unique, protective intestinal microbiome and that
this microbiome may provide protection against the excessive intestinal inflammation of prematurity by stimulating “pioneer” bacteria.
We found that the intestinal microbiome composition
of preterm infants differed over time depending on feeding with MBM, PDHM, or IF and that these differences
are also influenced by gestational age at birth and
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Fig. 6 Microbes that are discriminative of infant diet. Histogram of linear discriminant analyses (LDA) effect size (LEfSe) method identified taxa
that are most associated with microbiomes of MBM- and IF-fed infants. No characteristic taxa were observed within PDHM-fed infants, suggesting
a more heterogeneous response that largely overlaps with either IF or MBM groups

postnatal age at the time of observation. The microbiomes of infants who were fed MBM clustered separately from the infants who were fed IF after the first
3 weeks following birth. The intestinal microbiome of
infants fed IF was most influenced by differences in gestational age, while the intestinal microbiome of infants
fed MBM was more resilient to the influence of gestational age, following a similar trajectory regardless of the
gestational age at birth or postnatal age at the time of
measurement. Feeding with PDHM had a varied influence on the intestinal microbiome based on gestational
age of the infant. In infants born prior to 28 weeks,
PDHM did not bring the infants to an MBM-like intestinal microbiome but did influence colonization by specific taxa. Infants who were greater than 28 weeks and
fed PDHM did develop a microbiome that more closely
resembled that of the MBM-fed infants. These observations differ from a previous report [9] suggesting that
diet and other environmental factors (i.e., the delivery
mode or perinatal antibiotics use) only delayed the final
composition of intestinal microbiota rather than having
a meaningful influence on the assembly of the microbiome during early infancy. In this study, by addressing
the influence of diet in preterm infants, we showed profound effects on the composition and diversity of the
colonizing intestinal population.
When the microbial structure was examined based on
diet, postnatal age at the time of sample collection, and
gestational age, 40% of the variance was explained by
these three factors. This suggests that feeding with
MBM may mask some of the influence of birth weight
and in turn, gestational age at birth. Maturation of the
gut (i.e., gestational age at birth) appears to drive the trajectory of colonization of the intestinal microbiome in a
nutritionally dependent manner, but only after the early
colonization period that appears to occur during the first

3 weeks of life. This may represent an (noisy) establishment period for the microbiome where bona fide commensals can get a foothold before host and dietary
factors select and enrich for their continued presence.
Together, MBM-fed infant samples appeared to be more
similar and robust in that they were less influenced by
birth weight or gestational age, a proxy for gut maturity,
while the converse is true for IF-fed infants where composition is greatly influenced by birth weight and gestational age.
When comparing the difference by linear mixedeffects modeling of diversity among the three groups of
preterm infants fed by different means, the findings reported here suggest that preterm infants fed IF start with
a less diverse, more uniform intestinal microbiome that
is overwhelmingly populated by just a few types of bacteria, while the infants fed MBM have a more diverse
microbiome earlier in life and as a result, a more gradual
trajectory towards greater diversity over time. The presence of more bacterial species early in life, as seen in the
MBM-fed infants, and the slower trajectory towards increased acquisition of diversity within the intestinal
microbiome may be preferable for the preterm infant
not only because a greater diversity early in life is likely
to be health promoting but also because a rapid increase
in microbial load may be associated with an overwhelming inflammatory response during infancy [32].
There are several factors unique to breast milk when
compared to infant formula that likely contributes to the
increased diversity observed in this study of preterm infants who are routinely administered antibiotics following birth. First, oligosaccharides present in breast milk
provide an energy source to the intestinal microbiome,
facilitating the growth of bacterial species, many of
which are characterized as beneficial (i.e., commensal
bacteria) to the infant gut [33, 34]. Second, breast milk
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contains multiple bacterial species, now referred to as
the milk microbiomes [35] that actively colonize the gut.
And third, breast milk contains other bioactive factors
such as secretory IgA, which has been shown to alter
colonization of the infant gut, protecting it against
pathogenic bacteria [36, 37]. None of these factors are
present in IF, presumably contributing to the lower diversity index initially observed among IF-fed preterm infants, as well as the more rapid acquisition of microbes,
the majority being acquired from the hospital environment. In sum, breast milk not only modifies the environment of the infant gut to protect against pathogenic
bacteria, it also facilitates colonization with commensal
bacteria that promote short- and long-term immune
health of the host.
Infants who receive MBM and have a greater number and diversity of bacterial species present in their
intestinal microbiome do not appear to have an immune system that is overwhelmed by the acquisition
of the bacteria present in their microbiome, which
are being introduced from the milk or the environment. A possible explanation is that during infancy,
the immune system is weakened for the purpose of
acquiring intestinal bacteria [32]. The resistance to
infections that is known to be suppressed during
infancy may be designed to prevent overwhelming inflammation associated with the process of bacterial
colonization following birth. Exposure to innate
defense proteins present in MBM is another factor
that is likely to mitigate intestinal inflammation and
immune system activation in the setting of a more diverse intestinal microbiome during infancy [38]. For
example, human milk is known to have host defense
properties as a result of proteins such as lactoferrin,
lysozyme, secretory IgA, IgG, secretory component,
and complement C3. While these have been shown to
be present at lower concentrations in milk expressed
from mothers following preterm birth, they are not
significantly different from that of the milk expressed
following a full-term gestation [39]. These findings
help explain why MBM-fed preterm infants, who we
show here to have a more diverse intestinal microbiome when compared to their IF-fed counterpart, do
not have an overwhelming immune response to acquisition of the microbiome following birth.
Finally, we investigated the impact of nutrition on the
microbiome composition by maturity at birth. Our data
provide further evidence suggesting that feeding with
MBM masks the influence of varied degrees of immaturity of the gut at birth. In contrast, feeding IF does not
appear to have this protective influence on the preterm
infant intestinal microbiome. This finding may further
explain the role that MBM plays in protecting the premature gut from NEC.
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Donated milk from milk banks, which was fed to the
infants in this study, undergoes complex handling following collection and prior to delivery. This typically includes two freeze thaw cycles, as well as the Holder
method of pasteurization. These processes have been
shown to alter the macro- and micronutrient content, as
well as the bioactivity of the milk. For example, PDHM
has been shown to be lower in sIgA and lactoferrin than
unpasteurized milk [40, 41]. More research on the influence of milk storage and pasteurization conditions relative to the specifics of the milk microbiome and
presence or absence of bioactive factors, including
HMOs and other glycans, is needed to guide the optimal
clinical utility of this milk.
Greater study of PDHM is needed in light of our limited understanding of the influence of storage and
pasteurization conditions on the bioactive content of
this milk, and importantly, whether this influences the
health of the preterm infant. Our study is one of the first
to explore differences in the assembly of the preterm infant intestinal microbiome following supplementation
with PDHM and provides important observations regarding the influence of diet on early microbial health.
Future work exploring markers of interaction between
the microbiome and the host (i.e., measures of host immune response to the microbiome and metabolism) will
be based on this study. Overall, we did not find supplementation with PDHM to have a striking influence on
the microbiome after the infants were transitioned onto
IF (this transitioned occurred by 4–5 weeks of age). We
did observe some similarities among VLBW infants fed
PDHM with their MBM counterparts [e.g., slower increases in bacterial diversity], but later samples resembled more often either those of IF group or a hybrid
composition intermediate between the MBM and IF
groups. While the infants fed PDHM did not clearly
cluster together with either the “MBM microbiome” or
the “IF microbiome,” there were some interesting differences based on birth weight and specific taxa present in
the microbiome. For example, when accounting for gestational age, we observed an overall similar colonization
levels for two of the four most abundant bacterial orders
in infants fed PDHM [i.e., better colonization of Enterobacteriales and Clostridiales like MBM-fed infants] but
still had considerably higher levels of Lactobacillales
similar to IF-fed infants. This is an important finding as
it suggests that for these infants, exposure to PDHM
prior to IF has an influence on some members of the
microbiome that mirror that of the MBM-fed infants.
More research is needed, but these findings suggest that
there may be some influence on the microbiome associated with early exposure to PDHM when compared to
IF, perhaps as a result of specific glycans that survive the
milk storage and pasteurization processes.
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In this study, we analyzed specific bacteria in each
feeding group. Clearly, these bacterial taxa differed
between the MBM-fed and IF-fed groups. As stated,
the PDHM group had an intermediate response. We
then sought to determine the persistent effect of diet
on microbiome composition. Again, the MBM group
clustered together regardless of birth weight while the
IF group was strongly influenced by birth weight.
These preliminary observations indicate that mode of
feeding, particularly MBM, had a specific influence on
the nature of microbiota colonization in the preterm
infant. Further analysis will be necessary to identify
specific species and strain differences before more
studies can be done.
The studies reported here suggest that expressed
MBM has a significant impact on initial colonization of
the preterm infant’s intestine and differs from other
forms of neonatal nutrition. Moreover, this work suggests that the association of nutrition and microbiota
may be key for maintaining intestinal health and in turn
the prevention of NEC in this patient population. However, to demonstrate a direct association, further analyses are needed that employ a combination of isolates
of specific species and in vitro techniques that we have
pioneered (e.g., a fetal human small intestinal cell line
(H4 cells) [42], fetal intestinal organ cultures [43], fetal
intestinal xenografts [44], and organoids [45]), which
could help to determine if these species specific breast
milk-stimulated bacteria inhibit the intestinal inflammatory response. These observations should provide possible new probiotic protocols in combination with
expressed breast milk that can be used in clinical trials
and then possibly incorporated into routine care of the
preterm infant.

Conclusions
The preterm infant intestinal microbiome is influenced
by postnatal time, gestational age, birth weight, and nutritional exposures. Feeding with MBM appears to mask
the influence of birth weight, suggesting a protective effect against gut immaturity of the preterm infant early in
life. Further study is needed regarding the influence of
feeding with PDHM or IF on acquisition of the intestinal
microbiome, which based on our results appears to
occur in a gestational age dependent manner. These
findings not only suggest a microbial mechanism underpinning the body of evidence showing that breast milk
promotes intestinal health of the preterm infant, but also
the dynamic interplay of host and dietary factors that facilitate the colonization of and enrichment for specific
microbes during establishment of the preterm infant intestinal microbiota.
Methods
Study cohort and design

The infants included in this study were an otherwise
healthy population of preterm infants born prior to
32 weeks of gestation. The cohort of infants was carefully assembled such that there were three groups of 10
infants that differed only on their nutritional exposures
of MBM, PDHM, and IF. Inclusion in one of the three
groups required that the infant be fed 100% MBM, 100%
IF, or the hospital’s PDHM protocol. Within the three
groups of infants, other than nutritional history, there
were no statistically significant differences in gestational
age, birth weight, or mode of delivery. Neonatal morbidities such as incidence of patent ductus arteriosus
(PDA), sepsis, or necrotizing enterocolitis (NEC) were
also used as exclusion criteria for selection of this cohort

Table 1 Descriptive characteristics of preterm infants (n = 30)
MBM (n = 10)

PDHM (n = 10)

IF (n = 10)

p

Mean (SD)
Birth weight (g)

1044 (257.6)

1070 (421.9)

1175 (348.3)

0.660

Gestational age (weeks)

28.4 (1.5)

28.4 (2.1)

28.2 (2.5)

0.971

Days to full feeds

15.10 (4.2)

16.4 (8.1)

14.45 (6.8)

0.794

3.8 (1.8)

5.4 (3.8)

3.9 (2.0)

0.359

2 (20)

2 (20)

0.332

First day of enteral feeding

N (%)
Sepsis

0 (0)

NEC

0.338

Medical

0 (0)

1 (10)

0 (0)

Surgical

0 (0)

0 (0)

0 (0)

Perf
PDA

0 (0)

0 (0)

0 (0)

1 (10)

1 (10)

3 (30)

0.778

9 (90)

9 (90)

9 (90)

0.809

Birth mode
Cesarean section

MBM maternal breast milk, PDHM pasteurized donor human milk, IF infant formula
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and thus were also not significantly different between
the study groups. The considerations given to study design and cohort assembly in this research resulted in our
ability to evaluate the influence of diet on the preterm
infant intestinal microbiome over time. These results are
shown in Table 1. The study design is shown in Additional file 4: Figure S1 along with accompanying sample
metadata in Additional file 1: Table S1.
Clinical methods

All study procedures followed a protocol that was approved by the Partner’s Human Research Committee
(IRB) for Brigham and Women’s Hospital and Massachusetts General Hospital (Protocol #2012-P-002453).
All infants were born at Brigham and Women’s Hospital
in Boston, MA, and cared for in a single-center
Newborn Intensive Care Unit (NICU). Fecal samples
were collected from preterm infants born prior to
32 weeks of gestation from birth until discharge or
60 days of life, whichever came first. Briefly, diapers with
fecal samples were collected daily by the bedside nurse,
placed in a specimen bag, and stored at 4 °C for no more
than 24 h. Samples were processed daily, which involved
extraction of fecal material from infant diapers using
sterile procedures, and immediately frozen at −80 °C degrees until analyzed. The nutritional intake of the infants
was prospectively monitored but never influenced by
this observational study. When infants who were fed
predominantly 100% MBM, 100% IF, or the standard
hospital’s PDHM protocol were identified, their fecal
samples were selected for analysis in this study. Following the hospital protocol, infants who were fed PDHM
transitioned to IF after they achieved full enteral feeding
(defined as >140 cc/kg/day). In addition, infants on this
protocol weighing less than 1000 g at birth were required to exceed 1000 g in weight prior to transitioning
from PDHM to IF.
Adjusted gestational age is calculated by adding postnatal day to gestational age at birth. For example, an infant born at 24 weeks who is now 16 days old has an
adjusted gestational age of 26 weeks and 2 days, and an
infant who is born at 26 weeks who is now 2 days old
has an adjusted gestational age of 26 weeks and 2 days.
Adjusted gestational age, sometimes called corrected age
or post conceptual age, is often used to give a more accurate assessment of the overall maturity of the preterm
infant and to compare across infants regardless of gestational age at birth.
DNA extraction and sequencing

Samples were stored at −80 °C until the time of analysis.
At the time of analysis, DNA was isolated from approximately 200 mg of fecal material using a commercially
available kit that included a bead-beating step (MO-Bio,

Page 12 of 15

Carlsbad, CA). Isolated DNA from these samples (n =
221) was then arrayed into 96-well plates, quality determined (agarose gel), quantity normalized (by nanodrop
and/or PicoGreen), and stored at −20 °C until further
processing. The V4–V5 region of the 16S rRNA gene
was amplified using 515 F (5′- CCTACGGGAGGCAG
CAG -3′) and 806R (5′- CCGTCAATTCMTTTRAGT
-3′) with unique Golay-barcoded primers (on the reverse
primer) and sequencing adapters as described in the Earth
Microbiome Project (http://www.earthmicrobiome.org/;
[46]). To construct sequencing libraries, amplicons were
purified and pooled to equimolar concentrations
(PicoGreen), then sequenced using an Illumina MiSeq sequencer (paired-end 250-bp reads with v2 500 cycles kit).
The raw fastq files from sequencing were processed
with the QIIME software package (v1.7.0) [47]. Briefly,
sequences were truncated at the first low-quality base
and quality filtered to remove reads with an average
quality score below 25, reads shorter than 225 bp, reads
with more than 1 ambiguous base, primer mismatches,
and erroneous barcodes that could not be corrected
using the Golay barcodes. Chimeric reads were removed
using ChimeraSlayer [48]. The resulting dataset of quality filtered, non-chimeric of 16S rRNA gene sequences
were down-sampled randomly to a maximum of 25,000
reads per sample for ease of analysis, and de novo operational taxonomic unit (OTU) picking was performed
with the uclust option in QIIME [49]. Representative
OTU sequences were aligned using the PyNAST algorithm with a minimum percent identity of 80% [50].
Taxonomic assignment of representative OTUs was
completed using the Ribosomal Database Project (RDP)
classifier [51] (greengenes 12_10). OTUs that were not
identified in at least two independent samples with at
least ten total reads and samples with less than 2145
reads were filtered from the dataset. 2501 OTUs were
identified in the final dataset, which included 199 samples with a median of 23,309 per sample and a total of
4.1 million total reads.
For estimates of alpha diversity (within sample) and
taxa relative abundance, samples were rarefied to
2145 sequences to allow for inclusion of all samples,
while beta-diversity (between sample) metrics were
rarefied to 6945 sequences (191 total samples) to
allow for greater discrimination of microbiome composition. Alpha diversity metrics—i.e., Shannon index
(H′)—were computed within QIIME using default parameters and plotted using phyloseq [52]. Principle
component analyses (PCA) were completed using
Bray-Curtis dissimilarity distance matrices [53] to facilitate comparisons of presence/absence patterns between samples; Bray-Curtis matrices best explained
the variance of the samples (highest % variation explained by the top three PCA coordinates), though
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weighted and unweighted UniFrac metrics [51, 54]
(among others) were also examined.
Statistical analyses

Infant microbiome characteristics were assessed for their
significance using the R software package (version 3.2.4;
http://www.r-project.org/). Normally distributed variables (i.e., Shannon index) were statistically tested by an
unpaired t test for two independent groups or a one-way
analysis of variance (ANOVA) for multiple independent
groups. Changes in diversity over time were evaluated by
linear mixed-effects modeling in R using the nlme::lme
package (v3.1-128; [55]). The infant was included as a
random effect for both the intercept and the slope of the
estimated fit for analyses of postnatal day and adjusted
gestational age, while birth gestational age was also included in models based on postnatal days [nlme formulas − adjusted gestational age, ~1 + AdjSampleGestAge |
InfantID; postnatal day, ~1 + SamplePNDay | InfantID +
1 | BirthGestAge]. Non-normally distributed variables
(e.g., UniFrac, Bray-Curtis PCA) were statistically tested
using PERMANOVA test followed by a Mann-Whitney
U test for two independent groups or a Kruskal-Wallis
test for multiple independent groups. Similar to diversity
measures, significance of taxa relative abundance was
determined using linear mixed-effects modeling as a
function of adjusted gestational age using Calypso
(http://bioinfo.qimr.edu.au/calypso/) [LME formula −
relative taxa abundance = InfantID + AdjSampleGestAge
+ StudyGroup]. We sought to minimize the prevalence of
zeros by summarizing taxa differences at the class level
(<10% of values) and minimize the influence of the
remaining zeros by transforming the datasets using arcsin
square root methods (similar to [9, 56]) prior to building
the LME models of relative taxa abundance. There are recent methods that explicitly address zero-inflated datasets
(i.e., ZIBR [57]); however, the requirements for samples at
the same timepoints in every condition were incompatible
with our cohort even after imputation of missing samples
[<30% of samples able to be used over a narrow range in
adjusted gestational age (32–34 weeks)]. Perhaps, with a
larger cohort of infants and relaxed tolerance of such
datasets in future versions of the software, these limitations can be overcome.
For all analyses, the threshold significance level was set
at 0.05. Corrections based on multiple testing were performed by the Benjamini-Hochberg false discovery rate
procedure [58]. Linear effect size (LEfSe) analysis was performed using the default parameters to identify features
that discriminated our dietary groups of interest [21].
Data including 16S rRNA gene data and metadata has
been made available via the SRA database. The SRA accession number for publications referencing this dataset
is SRP079978.
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Additional files
Additional file 1: Table S1. Per sample key metadata parameters.
Table S2. Per sample Shannon diversity indices. Table S3. Mean taxa
relative abundance values by postnatal time and birth weight class.
Table S4. Mean taxa relative abundance values by birth weight class
alone. (XLS 106 kb)
Additional file 2: Figure S2. Bacterial diversity within nutrition groups
is selectively sensitive to gestational age and birth weight. Box and
whisker plots of Shannon diversity indices for each of the study groups
by postnatal age (<3 weeks (early) vs. >3 weeks (late)) summarized by (A)
birth gestational groups [<26 weeks, 27–29 weeks and 30–32 weeks] and
(B) birth weight [ELBW and VLBW]. Samples plotted included those
>7 days post antibiotic exposure for both panels [118 samples]. LME
models of significance as a function of diet and gestational age (p <
0.001) or postnatal day (p < 0.05) are noted in Fig. 3. (PDF 2200 kb)
Additional file 3: Figure S3. Genera co-occurrence analyses. Spearman
rank co-efficient analyses of relative abundance of a given genera in all of
the 199 samples as a group. Strong negative correlations between select
Enterobacteriales [Enterobacter, Trabusiella and Citrobacter] and Bacillales
[Staphylococcus and Bacillus] are shown. (PDF 2540 kb)
Additional file 4: Figure S1. Study design for longitudinal
examination of nutritional exposures on preterm infant microbiome.
Infants grouped by one of three feeding groups: mothers breast milk
(MBM), pasteurized human donor milk (PDMH), and infant formula (IF).
Samples analyzed on days indicated with an “X”. Feeding code for each
day as follows: gray = NPO, red = MBM, blue = PDHM, yellow = IF. Days
when a combination of feeding types were fed indicated in purple
(MBM/PDHM), orange (MBM/IF), green (PDHM/IF), or brown (MBM, PDHM, IF).
Birth delivery mode indicated by cesarean section (CS) or vaginal (V).
Maternal antibiotics during labor and birth indicated by yes (Y). (PDF 2210 kb)
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